GHP Q1 2026 to have technology that just works. That’s especially needed for the high-stakes world of clinical trials. We’re proud to be seen as an innovator and leader in our space, with five U.S. patents for our platform architecture and independent recognition from analysts for our impact on clinical trial technology.” Building on its exceptional success, Suvoda has developed a groundbreaking patient app. The Suvoda patient app provides trial participants with a single, intuitive mobile experience that allows them to manage the essentials of their trial needs in one unified place. On their own device, users can receive visit reminders and view upcoming visit schedules, complete eCOA questionnaires and fill out daily diaries, arrange travel details, and track patient payments and reimbursements, all without the unnecessary burden of juggling emails, calls, and papers. The bright minds at Suvoda created Sofia, an AI assistant. Currently available on Suvoda IRT, the company’s software for patient randomisation and trial drug supply management, with plans to extend across the Suvoda Platform. Sofia transforms what used to be multi-screen, multi-click workflows into simple, auditable conversations. With Sofia, Suvoda aims to help study teams quickly access trial data, reports, and documentation through a secure, streamlined chat interface. Together, these innovations enable Suvoda to further unify the digital experience for patients while simplifying day-to-day work for sites and sponsors. With all features comprised in a sole, user-friendly interface, the patient app promises higher patient engagement, fewer missed visits, and better participant retention. With many administrative tasks now streamlined into a guided, self-service experience for patients, site burden is reduced as staff are free to shift their focus from coordination to clinical care. Furthermore, study teams can make faster and more confident decisions with support from Sofia. Without compromising role-based access or blinding, the AI technology can surface information such as inventory levels, shipment, or visit data; create tables and charts; and link directly to relevant sections of user manuals. Powered by the same unified Suvoda Platform, these innovations make for a more connected ecosystem overall, allowing data and workflows to move smoothly between patient, site, and sponsor tools. Of course, as with many industries, one of the biggest developments on everyone’s mind is the use of AI. The technology has significant potential, but there is absolutely no room for error in the field of clinical trials, when dealing with patient’s health or the carefully designed protocols of a clinical trial study. With this understanding, Suvoda’s approach to AI is innovation with guardrails: every AI use case must be reliable, secure, and fully auditable. This can be seen most clearly in Sofia. The AI agent is designed to only answer questions it has been taught to answer using expert-authored instructions, has been validated by humans, and operates within strict role-based access that maintains study blind. What’s more, with “zero-day” data retention, Sofia never exposes data beyond a user’s permissions and never uses customer data to train public models. “AI brings both opportunities and challenges to our industry,” Robin stated. “Sponsors and sites want faster, simpler ways to work, but they’re rightly cautious about AI risk. We’ve turned that tension into an advantage by harnessing AI in ways that support our users while also preserving the precision that our industry demands.” In the coming years, Suvoda will continue to combine innovation with expertise so that it can support end users whilst responding directly to the needs of the industry. In alignment with this mission, the company is excited to deliver on its promise of the Suvoda-Greenphire merger announced last year. By uniting its core systems for trials, comprising randomisation, drug supply, consent, and eCOA – with Greenphire’s strength in patient payments, patient travel, budgeting, and site payments, Suvoda is making significant strides in building a truly endto-end platform that serves the needs of clinical trial sponsors. Through 2026 and beyond, Suvoda seeks to help sponsors move away from fragmented point solutions and transition to its unified suite of solutions. The benefits are myriad: patients and sites can experience a single, intuitive platform and Suvoda app that handles their needs; sites deal with fewer systems and less manual reconciliation so they can focus on care; while sponsors and CROs gain a trusted partner providing connected clinical and financial data, allowing them to see what is happening across enrolment, logistics, and budgets, and act faster. Ultimately, Suvoda’s unified tech suite opens up workflow improvements that the healthcare sector has been long overdue. Through its pioneering platform, patient-preferred app, and complementing AI assistant, the company has successfully developed a comprehensive ecosystem that streamlines the clinical trial process for all involved. With plans for further innovation already underway, Suvoda is gearing up for another year of making meaningful impact on the state of human healthcare, a mission that has earned it recognition as the Most Innovative Clinical Trial Technology Firm 2026. Company: Suvoda Web Address: www.suvoda.com
RkJQdWJsaXNoZXIy NTY1MjM3